Translating research to real-world innovations

Through start-up companies, clinical trials, and industry collaborations, research from Department of Biomedical Engineering (BME) faculty is improving and saving people’s lives.

Forming start-ups

A slew of start-up companies have been formed based on our faculty's technology, bringing meaningful change to healthcare.

Patient wearing a headset and holding a device that inserts into their mouth

A medical device for tinnitus

Neuromod Devices

In the largest clinical trial of its kind, the start-up's device significantly reduced tinnitus and sustained therapeutic results for a year.

Hubert Lim

Hand holding an engineered heart valve

Lab-created heart valves

Vascudyne, Inc.

Vascudyne's heart valves grow with the recipient, which — if confirmed in humans — could prevent the need for repeated surgeries in kids with congenital heart defects.

Robert Tranquillo

patient lifting leg

Function after paralysis

StimSherpa

With StimSherpa’s neuromodulation platform, clinicians can customize spinal cord stimulation for each individual patient. This helps patients regain control over volitional movement and bodily functions.

Tay Netoff

BME PhD student helps design device and create start-up

Claire Kaiser

 

Kaiser, Prof. Hubert Lim, and team co-created SecondWave Systems, a company that aims to develop and commercialize a wearable arthritis device.

Aperios Technologies
Zhi Yang

Fasikl
Zhi Yang

SecondWave
Hubert Lim

 

Sollievo Pharmaceuticals
Ronald Siegel

VitriStor
John Bischof

Vigilant Diagnostics
John Bischof

Dr. Alex Herman (left) and Dr. David Darrow stimulate and record brain activity to improve April Reasor's pain.

Neurostimulation helps relieve patient’s pain

A Minnesota woman no longer suffers from chronic pain, thanks to a neurostimulation approach that’s based on research from our department and the UMN Medical School. 

Pain was treated via cortical brain stimulation, with outstanding results: Her self-assessed pain dropped from eight (out of ten) to zero. 

Tay Netoff

Conducting clinical trials

Our location is uniquely well-suited for clinical trials. We're situated in a major urban area next to the University of Minnesota Medical School, other health science units, and a hospital, and in the heart of a world-leading health technology innovation cluster.

Covid-19 spelled out in pills

COVID-19 simulator guides clinical trials

Our researchers developed a biophysical computer model that the UMN Medical School is using to predict which treatments and therapies show promise before testing them in clinical trials. Originally launched to test metformin, the COVID-19 clinical trial has been expanded to include fluvoxamine and ivermectin.

David Odde

Brain

Accelerating neuromodulation technology development with Abbott

A collaboration between our faculty and Abbott aims to rapidly develop new neuromodulation technologies. In its first six months, they've launched a clinical trial and enrolled its first study participant to discover how different electrical waveforms affect patients with chronic pain.

Hubert Lim, Tay Netoff

Cancer cells

Accelerating new therapies

Researchers are pioneering a biophysics-based simulator that can predict tumor progression.

By providing a multiscale computational platform, the simulator will accelerate the development of new therapies. 

David Odde

Collaborating with industry

With more than 500,000 people employed in the local health technology sector, the opportunities for collaboration are endless. Many of our faculty team up with local industry contacts to translate their research into products that make people's lives better.

skyscrapers

Industrial Advisory Board (IAB)

Our department's work is guided by input from biomedical engineering leaders at local companies. The board aims to:

  • Connect students and faculty with industry stakeholders.
  • Accelerate innovation in health care.
  • Create an environment of collaboration and innovation.
ANI prototype

Groundbreaking auditory nerve implant attracts industry investment 

Blackrock Neurotech announced plans to invest in a novel auditory nerve implant (ANI) device that restores hearing for the deaf. The ANI device technology is being developed as part of an NIH-supported effort in which BME Professor Hubert Lim serves as lead researcher. 

Hubert Lim

Neuroengineering reserachers standing around a screen and a device

Researching together

Our neuroengineering researchers collaborate extensively with local medtech companies. Endeavors range from conducting basic and translational research projects funded by the companies to holding consulting positions.

Neuroengineering course

Course: Translating and commercializing neurotechnology

A free, comprehensive course is easing the journey from lab success to patient benefit. Through online lectures and hands-on training, the course shows how entrepreneurs and academics can translate and commercialize neurotechnology.

Matt Johnson

Students presenting senior projects at a poster session

Training trailblazers

Our undergraduate program prepares students for careers in the medtech industry.

Students pick one of nine emphasis areas—such as digital health, medical device design, cell and tissue engineering, or neural engineering—and couple classroom experiences with robust co-op and internship opportunities.